Systemic Sclerosis - Diffuse Cutaneous
1 clinical trials · Condition
◉ Watch Systemic Sclerosis - Diffuse Cutaneous
| Record | Firm | Date |
|---|---|---|
| KYSA-5: A Study of Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects With Systemic Sclerosis (NCT06400303) | Kyverna Therapeutics | 2024-08-06 |
Track Systemic Sclerosis - Diffuse Cutaneous automatically
Every clearance here is in the API, with alerts when new ones post.